Targeting the BspC-vimentin interaction to develop anti-virulence therapies during Group B streptococcal meningitis.
Manzer HS, Villarreal RI, Doran KS. Targeting the BspC-vimentin interaction to develop anti-virulence therapies during Group B streptococcal meningitis. PLoS Pathog. 2022 03; 18(3):e1010397.